The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

The Washburn University class taught physical therapist assistant students a unique way to help patients living with ...

Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in ...

Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating individuals living with Parkinson’s disease At 24 months, data from the Phase 1 exPDite trial ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson's ...

Many people with Parkinson’s disease experience speech and swallowing difficulties that can weaken their voice or make them difficult to understand. Thanks to a grant from the Parkinson Voice Project, ...

SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...

Learn to manage anxiety in advanced Parkinson's with treatments like therapy, medication, lifestyle changes, and more to improve quality of life. Discover effective strategies today.

BLOOM (TAMPA) – Vanessa Alcala, a bilingual Speech-Language Pathologist, Certified Dementia Practitioner, and founder of TheraVolve Wellness Co., recently joined Gayle Guyardo, host of the globally ...

Regene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its lead product, NouvNeu001, has been ...